On September 16, 2022 Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3M-052 liposomes): In vitro characterization
On June 25, 2021 Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy
On June 5, 2018 Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica
On February 7, 2017 Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica
